Status

In portfolio

Country(ies)

Algeria

Sector

Deal Type

Growth

Investment Fund

Mediterrania Capital IV

Date of Investment

May 2024
Biopharm Logo

Biopharm is an Algerian pharmaceutical platform integrating manufacturing, distribution, logistics and medical promotion to expand access to medicines across the country. The company was founded in 1992 and operates through eight subsidiaries and a nationwide platform comprising four manufacturing sites. Biopharm’s mission lays in strengthening access to essential medicines through local manufacturing and nationwide distribution, contributing to the resilience of Algeria’s healthcare system.